Related Experiment Videos
Left ventricular hypertrophy. Significance in cardiac morbidity and mortality
1Hebrew Hospital for Chronic Sick, Bronx, NY 10475.
Insights
Left ventricular hypertrophy (LVH) is linked to heart disease, increasing risks. Treating the cause may reverse LVH, potentially lowering cardiovascular events.
Area of Science:
- Cardiology
- Medical Diagnostics
- Clinical Research
Background:
- Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular morbidity and mortality.
- Patients with LVH exhibit higher prevalence of ventricular tachycardia, complex ventricular arrhythmias, and silent ischemia.
Purpose of the Study:
- To highlight the diagnostic superiority of echocardiography over electrocardiography for LVH.
- To explore the potential of treating underlying cardiovascular disorders to regress LVH and reduce cardiovascular events.
Main Methods:
- Review of literature on left ventricular hypertrophy and cardiovascular disease.
- Analysis of diagnostic accuracy of echocardiography versus electrocardiography.
- Examination of data from the Framingham Heart Study regarding LVH regression and cardiovascular outcomes.
Main Results:
- Echocardiography demonstrates higher sensitivity and specificity in diagnosing LVH compared to electrocardiography.
- Regression of LVH through treatment of the underlying cardiovascular disorder is achievable.
- Data suggests that LVH regression may lead to a reduced incidence of cardiovascular events.
Conclusions:
- Left ventricular hypertrophy is a critical marker and contributor to cardiovascular disease progression.
- Effective diagnosis and treatment strategies targeting underlying causes can lead to LVH regression and improved cardiovascular outcomes.
Abstract:
Left ventricular hypertrophy caused by cardiovascular disease is a marker as well as a contributing factor for cardiovascular morbidity and mortality. Ventricular tachycardia, complex ventricular arrhythmias, and silent ischemia are more prevalent in patients with left ventricular hypertrophy than in those without. Echocardiography is more sensitive and more specific than electrocardiography in diagnosing the entity. Treatment of the underlying disorder may cause regression of left ventricular hypertrophy which, Framingham Heart Study data suggests, may reduce the incidence of cardiovascular events.